Nivalis Therapeutics (NVLS) Reports Q3 Loss of $0.39/Share
Tweet
Share
E-mailGet Alerts NVLS Hot Sheet
Price: $2.40 --0%
Financial Fact:
Income before income taxes: 51.05M
Today's EPS Names:
HMR, RZLV, ZEPP, More
Financial Fact:
Income before income taxes: 51.05M
Today's EPS Names:
HMR, RZLV, ZEPP, More
Join SI Premium – FREE
Nivalis Therapeutics (NASDAQ: NVLS) reported Q3 EPS of ($0.39), versus ($7.68) reported last year.
For earnings history and earnings-related data on Nivalis Therapeutics (NVLS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- PG&E downgraded by Wells Fargo, BMO as California wildfire reform falls short
- Getty Realty (GTY) Reiterated at Market Outperform by Citizens Amid Favourable Trends
- Paycom Software (PAYC) PT Raised to $285 at UBS
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
